Bladder function ‐ Stress incontinence · women with apical vaginal vault prolapse
Vaginal procedure probably leads to higher bladder Function ‐ Stress incontinence compared with sacral colpopexy (vault prolapse) (moderate certainty).
1 finding from 1 review
Surgery for recurrent prolapse · women with apical vaginal prolapse
Sacral colpopexy: laparoscopic showed no clear difference in surgery for recurrent prolapse compared with alternative approach (moderate certainty).
1 finding from 1 review
Prolapse on examination (Stage 2 or above) ‐ Any recurrent prolapse · women with apical vaginal prolapse
Sacral colpopexy: laparoscopic showed no clear difference in prolapse on examination (Stage 2 or more): Any recurrent prolapse compared with alternative approach (low certainty).
1 finding from 1 review
Any complications (Clavien‐Dindo > 3) · women with apical vaginal prolapse
It is very uncertain whether sacral colpopexy: laparoscopic changes any complications (Clavien‐Dindo > 3) compared with alternative approach (very low certainty).
1 finding from 1 review
Operating time · women with apical vaginal prolapse
1 finding from 1 review
Length of hospital stay · women with apical vaginal prolapse
1 finding from 1 review
Painful intercourse ‐ Dyspareunia · women with apical vaginal vault prolapse
Vaginal procedure showed no clear difference in painful intercourse ‐ Dyspareunia compared with sacral colpopexy (vault prolapse) (low certainty).
1 finding from 1 review
Operating time · women with apical vaginal vault prolapse
1 finding from 1 review
Costs · women with apical vaginal vault prolapse
1 finding from 1 review
Awareness of prolapse · women with apical uterine prolapse
It is very uncertain whether vaginal hysterectomy changes awareness of prolapse compared with sacral hysteropexy/cervicopexy (uterine prolapse) (very low certainty).
1 finding from 1 review
Live birth or ongoing pregnancy · assisted reproduction technology cycles
3 findings from 1 review
Premature LH surge ‐ Own oocytes ‐ PCOS (high‐responders) ‐ Early phase stimulation protocol ‐ Frozen embryo transfer · assisted reproduction technology cycles
1 finding from 1 review
no estimate extracted
1 study · 1 participants
GRADE not reported
Total oocytes ‐ Normoresponders ‐ Donor oocytes ‐ Early phase stimulation protocol ‐ Fresh embryo transfer (MPA 10 mg/day versus GnRH antagonists) · assisted reproduction technology cycles
1 finding from 1 review
Total oocytes ‐ PCOS (high‐responders) ‐ Own oocytes ‐ Early phase stimulation protocol ‐ Frozen embryo transfer (micronised progesterone 100 mg/day versus GnRH antagonists) · assisted reproduction technology cycles
1 finding from 1 review
MII oocytes · assisted reproduction technology cycles
1 finding from 1 review
Total dose of gonadotropins · assisted reproduction technology cycles
1 finding from 1 review
MII oocytes ‐ PCOS (high‐responders) ‐ Own oocytes ‐ Early phase stimulation protocol ‐ Frozen embryo transfer (micronised progesterone 100 mg/day versus GnRH antagonists) · assisted reproduction technology cycles
1 finding from 1 review
Moderate or severe OHSS · assisted reproduction technology cycles
1 finding from 1 review
Duration of stimulation (days) ‐ PCOS (high‐responders) ‐ Own oocytes ‐ Early phase stimulation protocol ‐ Frozen embryo transfer (micronised progesterone 100 mg/day versus GnRH antagonists) · assisted reproduction technology cycles
1 finding from 1 review
Total dose of gonadotropins (IU) ‐ Poor responders (MPA 10 mg versus GNrH antagoninsts ‐ Own oocytes ‐ Early phase stimulation protocol · assisted reproduction technology cycles
1 finding from 1 review